US FDA's Postmarket Study Requirements: Industry Wants Standardization, Expert Input
Executive Summary
PhRMA, BIO and Pfizer call for predictable process for setting postmarket commitments and requirements, periodic reevaluation of their necessity and feasibility, and FDA acceptance of novel trial designs.